首页 > 最新文献

International Journal of Pharmacy Practice最新文献

英文 中文
Self-management of chronic diseases during Ramadan: patients' perceptions, practices, awareness, and quality of life. 斋月期间慢性病的自我管理:患者的观念、做法、意识和生活质量。
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2026-02-14 DOI: 10.1093/ijpp/riag007
Basima A Almomani, Shoroq M Altawalbeh, Nour A Al-Sawalha, Muna Oqal, Roa'a N Elayyan

Objectives: To assess the perceptions, practices, and awareness of patients with chronic diseases in Jordan regarding Ramadan self-management, and to identify factors influencing their quality of life based on utility scores.

Methods: A cross-sectional, survey-based study was conducted in outpatient clinics and hospital pharmacies across multiple centres in Jordan, following Ramadan. Muslim patients who self-reported having chronic diseases and had been receiving their regular medications for at least one year were included and interviewed face-to-face.

Key findings: A total of 900 patients were included in the study. Most participants (82.9%) fasted during Ramadan, of whom 90.8% did not consult a physician beforehand, and 69.4% did not undergo laboratory testing to assess disease control before fasting. Most patients (94%) considered physicians as their main source of information on medication use during Ramadan (94%). Participants generally showed good awareness of medications and procedures that break fasting. Higher levels of agreement with the Jordanian General Iftaa' Department on fasting were significantly linked to having a university education and an income of ≥500 JOD (P value < .5). Additionally, male gender, university degree, income of ≥500 JOD, village residency, non-smoking status, and fewer comorbidities or medications were predictors of higher utility scores (P value <.5).

Conclusions: Most participants were able to carry out daily activity, despite few seeking medical advice or undergoing lab tests to assess disease control before fasting. They were generally aware of medication routes and clinical procedures that break the fast. Emphasizing pre-Ramadan physician consultations and educational programs is recommended.

目的:评估约旦慢性病患者对斋月自我管理的看法、做法和意识,并根据效用评分确定影响其生活质量的因素。方法:在斋月之后,在约旦多个中心的门诊诊所和医院药房进行了一项基于调查的横断面研究。自我报告患有慢性疾病并已接受常规药物治疗至少一年的穆斯林患者被包括在内并进行面对面访谈。主要发现:共有900名患者被纳入研究。大多数参与者(82.9%)在斋月期间禁食,其中90.8%事先没有咨询医生,69.4%在禁食前没有接受实验室检测以评估疾病控制。大多数患者(94%)认为医生是他们在斋月期间用药信息的主要来源(94%)。参与者普遍表现出对药物和断食程序的良好认识。与约旦Iftaa总部关于禁食的较高水平的一致性与拥有大学教育和收入≥500 JOD (P值)显着相关。结论:大多数参与者能够进行日常活动,尽管很少有人在禁食前寻求医疗建议或接受实验室检查以评估疾病控制。他们通常知道打破斋戒的用药路线和临床程序。建议强调斋月前的医生咨询和教育计划。
{"title":"Self-management of chronic diseases during Ramadan: patients' perceptions, practices, awareness, and quality of life.","authors":"Basima A Almomani, Shoroq M Altawalbeh, Nour A Al-Sawalha, Muna Oqal, Roa'a N Elayyan","doi":"10.1093/ijpp/riag007","DOIUrl":"https://doi.org/10.1093/ijpp/riag007","url":null,"abstract":"<p><strong>Objectives: </strong>To assess the perceptions, practices, and awareness of patients with chronic diseases in Jordan regarding Ramadan self-management, and to identify factors influencing their quality of life based on utility scores.</p><p><strong>Methods: </strong>A cross-sectional, survey-based study was conducted in outpatient clinics and hospital pharmacies across multiple centres in Jordan, following Ramadan. Muslim patients who self-reported having chronic diseases and had been receiving their regular medications for at least one year were included and interviewed face-to-face.</p><p><strong>Key findings: </strong>A total of 900 patients were included in the study. Most participants (82.9%) fasted during Ramadan, of whom 90.8% did not consult a physician beforehand, and 69.4% did not undergo laboratory testing to assess disease control before fasting. Most patients (94%) considered physicians as their main source of information on medication use during Ramadan (94%). Participants generally showed good awareness of medications and procedures that break fasting. Higher levels of agreement with the Jordanian General Iftaa' Department on fasting were significantly linked to having a university education and an income of ≥500 JOD (P value < .5). Additionally, male gender, university degree, income of ≥500 JOD, village residency, non-smoking status, and fewer comorbidities or medications were predictors of higher utility scores (P value <.5).</p><p><strong>Conclusions: </strong>Most participants were able to carry out daily activity, despite few seeking medical advice or undergoing lab tests to assess disease control before fasting. They were generally aware of medication routes and clinical procedures that break the fast. Emphasizing pre-Ramadan physician consultations and educational programs is recommended.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146197619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Developing National Health Service pharmacists as researchers: learning from the Scottish Pharmacist Clinical Academic Fellowship Programme. 发展国家卫生服务药剂师作为研究人员:从苏格兰药剂师临床学术奖学金计划学习。
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2026-02-14 DOI: 10.1093/ijpp/riag008
Clare Depasquale, Susan Roberts, Leon Zlotos, Marion Bennie, Andrew Sturrock, Scott Cunningham

In the United Kingdom (UK), the vision is to further develop the pharmacy workforce through career development pathways aligning to the Royal Pharmaceutical Society's post-registration foundation, advanced, and consultant practice curricula, which align with the four pillars of advanced practice recognized across multiple healthcare professionals-clinical practice, leadership and management, education, and research. However, it has been recognized that research capacity, competency, and confidence within the pharmacy profession require development. It has been noted that it is this 'pillar' that most frequently impedes successful credentialing at both 'Core advanced' and 'Consultant levels'. A report presenting the findings of a UK-wide call for evidence on clinical academic careers in pharmacy outlines recommendations to embed a research culture in pharmacy careers, develop a clinical academic pathway for pharmacy, and provide a pipeline of pharmacy research leaders. The establishment of such pathways would provide opportunities for building capacity within the profession. The Scottish Pharmacist Clinical Academic Fellowship (SPCAF) programme was created to develop a network of Clinical Academic Pharmacist posts; a collaborative initiative between National Health Service Education for Scotland and the two Pharmacy Higher Education Institutions in Scotland is aimed at developing pharmacists as researchers to advance pharmaceutical care within the National Health Service in Scotland. This commentary presents a summary of an archival review completed as part of a wider research programme that adopted a case study approach with the purpose of evaluating the SPCAF programme cohort 1 (2021-23). The scope is to support others looking to develop similar practice-based research programmes aiming to build research capacity, competence, and confidence in the pharmacy workforce.

在英国(UK),愿景是通过与皇家药学会注册后基础、高级和顾问实践课程相一致的职业发展途径进一步发展药房劳动力,这些课程与多个医疗保健专业人员认可的高级实践的四大支柱——临床实践、领导和管理、教育和研究相一致。然而,人们已经认识到,研究能力,能力和信心在药学专业需要发展。已经注意到,正是这一“支柱”最经常阻碍“核心高级”和“顾问级别”的成功认证。一份报告展示了英国范围内对药学临床学术职业证据的呼吁的结果,概述了在药学职业中嵌入研究文化的建议,为药学发展临床学术途径,并提供药学研究领导者的管道。建立这样的途径将为专业内的能力建设提供机会。苏格兰药剂师临床学术奖学金(SPCAF)计划是为了发展临床学术药剂师职位网络而创建的;苏格兰国民保健服务教育机构与苏格兰两所药学高等教育机构之间的一项合作倡议,旨在将药剂师培养为研究人员,以促进苏格兰国民保健服务机构内的药学服务。本评论是一份档案综述的摘要,该综述是一个更广泛的研究项目的一部分,该项目采用案例研究方法,目的是评估SPCAF项目队列1(2021-23)。其范围是支持其他希望开发类似的基于实践的研究项目的机构,这些项目旨在建立药学工作人员的研究能力、能力和信心。
{"title":"Developing National Health Service pharmacists as researchers: learning from the Scottish Pharmacist Clinical Academic Fellowship Programme.","authors":"Clare Depasquale, Susan Roberts, Leon Zlotos, Marion Bennie, Andrew Sturrock, Scott Cunningham","doi":"10.1093/ijpp/riag008","DOIUrl":"https://doi.org/10.1093/ijpp/riag008","url":null,"abstract":"<p><p>In the United Kingdom (UK), the vision is to further develop the pharmacy workforce through career development pathways aligning to the Royal Pharmaceutical Society's post-registration foundation, advanced, and consultant practice curricula, which align with the four pillars of advanced practice recognized across multiple healthcare professionals-clinical practice, leadership and management, education, and research. However, it has been recognized that research capacity, competency, and confidence within the pharmacy profession require development. It has been noted that it is this 'pillar' that most frequently impedes successful credentialing at both 'Core advanced' and 'Consultant levels'. A report presenting the findings of a UK-wide call for evidence on clinical academic careers in pharmacy outlines recommendations to embed a research culture in pharmacy careers, develop a clinical academic pathway for pharmacy, and provide a pipeline of pharmacy research leaders. The establishment of such pathways would provide opportunities for building capacity within the profession. The Scottish Pharmacist Clinical Academic Fellowship (SPCAF) programme was created to develop a network of Clinical Academic Pharmacist posts; a collaborative initiative between National Health Service Education for Scotland and the two Pharmacy Higher Education Institutions in Scotland is aimed at developing pharmacists as researchers to advance pharmaceutical care within the National Health Service in Scotland. This commentary presents a summary of an archival review completed as part of a wider research programme that adopted a case study approach with the purpose of evaluating the SPCAF programme cohort 1 (2021-23). The scope is to support others looking to develop similar practice-based research programmes aiming to build research capacity, competence, and confidence in the pharmacy workforce.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146197656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of pharmacy education and pharmacy practice in developing pharmacists as researchers in Austria. 奥地利药学教育和药学实践在发展药学研究者中的作用。
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2026-02-13 DOI: 10.1093/ijpp/riag006
Olaf Rose, Johanna Pachmayr, Stephanie Clemens
<p><p>Clinical pharmacy and pharmacy practice research in Austria has evolved more slowly than in some other countries, but recent years have seen notable progress. Geographic disparities still limit access in certain regions, yet policymakers increasingly acknowledge the essential role of pharmacies, while remaining focused on cost containment. Curricula at universities vary, with most universities still focussing on pharmaceutical chemistry and traditional content and one university teaching pharmacotherapy and medication review to a higher extent. The switch to the bachelor's and master's degree system has increased research involvement, as all pharmacy students must complete two original research projects for their theses. These projects often interact with pharmacy practice. Various postgraduate pathways support continued involvement in research. Fostered by the theses, pharmacy education develops research competence across the entire cohort rather than limiting it to a small academic subset. However, maintaining research engagement after graduation remains difficult. Once pharmacists enter practice, particularly in community settings, limited institutional links, lack of protected time, and scarce funding opportunities tend to interrupt this trajectory. A few postgraduate programs provide structured pathways to continue academic or clinical research, yet participation is optional and dependent on individual motivation. Strengthening continuity between academic training and professional environments would help consolidate the existing research competencies and foster a more sustainable research culture within the profession. The recently introduced mandatory system of continuing professional education further supports this development by bringing academia and practitioners closer together and by promoting a culture of shared learning and ongoing inquiry. Although the number of clinical pharmacists remains relatively low, their presence on hospital wards is expanding and increasingly valued, while community pharmacies are also beginning to offer clinical pharmacy services. Strengthening Austria's pharmacy profession requires closer alignment between educational reform, professional practice, and health policy. Policymakers should make more systematic use of pharmacists' competencies as accessible first points of contact within primary care. Expanding their scope to include structured involvement in the pharmacotherapy of prevalent chronic diseases such as atherosclerosis, diabetes, and hypertension, as well as in screening and prevention programs, would not only improve population health but also bring translational research closer to everyday pharmacy practice. Evidence demonstrates that Austrian pharmacists are well prepared for expanded clinical responsibilities and show high professional motivation to assume such roles. These developments should be accompanied by targeted curricular reforms that strengthen clinical reasoning, interprofess
奥地利的临床药学和药学实践研究的发展速度比其他一些国家要慢,但近年来取得了显著进展。地理差异仍然限制了某些地区的获取,但政策制定者越来越认识到药房的重要作用,同时仍然关注成本控制。大学的课程各不相同,大多数大学仍然侧重于药物化学和传统内容,而一所大学则在很大程度上教授药物治疗和药物评论。学士和硕士学位制的转换增加了研究的参与,因为所有的药学学生必须在他们的论文中完成两个原始的研究项目。这些项目经常与药学实践相互作用。各种研究生途径支持继续参与研究。在这些论文的推动下,药学教育发展了整个群体的研究能力,而不是局限于一个小的学术子集。然而,毕业后保持研究投入仍然很困难。一旦药剂师进入实践,特别是在社区环境中,有限的机构联系、缺乏保护时间和缺乏资金机会往往会中断这一轨迹。一些研究生课程为继续学术或临床研究提供结构化的途径,但参与是可选的,取决于个人动机。加强学术训练和专业环境之间的连续性将有助于巩固现有的研究能力,并在专业内培育更可持续的研究文化。最近推出的强制性继续专业教育制度进一步支持了这一发展,使学术界和实践者更加紧密地联系在一起,并促进了共享学习和持续探索的文化。虽然临床药剂师的人数仍然相对较少,但他们在医院病房的存在正在扩大并日益受到重视,而社区药房也开始提供临床药学服务。加强奥地利的药学专业需要在教育改革、专业实践和卫生政策之间建立更紧密的联系。决策者应该更系统地利用药剂师的能力,作为初级保健中可获得的第一接触点。扩大他们的范围,包括有组织地参与流行慢性疾病的药物治疗,如动脉粥样硬化、糖尿病和高血压,以及筛查和预防项目,不仅可以改善人口健康,还可以使转化研究更接近日常的药学实践。证据表明,奥地利药剂师为扩大临床责任做好了充分准备,并表现出高度的专业动机来承担这些角色。这些发展应该伴随着有针对性的课程改革,以加强临床推理、跨专业合作和应用研究能力。欧洲研究和教育网络的国际合作和参与可以进一步提高奥地利的研究能力,并使国家进步与全球最佳实践相协调。通过衔接政策、教育和专业发展,药剂师可以从目前的多方面角色演变为以患者为中心的研究和循证医疗保健的积极贡献者,同时保持与继续教育和研究的密切联系。
{"title":"Role of pharmacy education and pharmacy practice in developing pharmacists as researchers in Austria.","authors":"Olaf Rose, Johanna Pachmayr, Stephanie Clemens","doi":"10.1093/ijpp/riag006","DOIUrl":"https://doi.org/10.1093/ijpp/riag006","url":null,"abstract":"&lt;p&gt;&lt;p&gt;Clinical pharmacy and pharmacy practice research in Austria has evolved more slowly than in some other countries, but recent years have seen notable progress. Geographic disparities still limit access in certain regions, yet policymakers increasingly acknowledge the essential role of pharmacies, while remaining focused on cost containment. Curricula at universities vary, with most universities still focussing on pharmaceutical chemistry and traditional content and one university teaching pharmacotherapy and medication review to a higher extent. The switch to the bachelor's and master's degree system has increased research involvement, as all pharmacy students must complete two original research projects for their theses. These projects often interact with pharmacy practice. Various postgraduate pathways support continued involvement in research. Fostered by the theses, pharmacy education develops research competence across the entire cohort rather than limiting it to a small academic subset. However, maintaining research engagement after graduation remains difficult. Once pharmacists enter practice, particularly in community settings, limited institutional links, lack of protected time, and scarce funding opportunities tend to interrupt this trajectory. A few postgraduate programs provide structured pathways to continue academic or clinical research, yet participation is optional and dependent on individual motivation. Strengthening continuity between academic training and professional environments would help consolidate the existing research competencies and foster a more sustainable research culture within the profession. The recently introduced mandatory system of continuing professional education further supports this development by bringing academia and practitioners closer together and by promoting a culture of shared learning and ongoing inquiry. Although the number of clinical pharmacists remains relatively low, their presence on hospital wards is expanding and increasingly valued, while community pharmacies are also beginning to offer clinical pharmacy services. Strengthening Austria's pharmacy profession requires closer alignment between educational reform, professional practice, and health policy. Policymakers should make more systematic use of pharmacists' competencies as accessible first points of contact within primary care. Expanding their scope to include structured involvement in the pharmacotherapy of prevalent chronic diseases such as atherosclerosis, diabetes, and hypertension, as well as in screening and prevention programs, would not only improve population health but also bring translational research closer to everyday pharmacy practice. Evidence demonstrates that Austrian pharmacists are well prepared for expanded clinical responsibilities and show high professional motivation to assume such roles. These developments should be accompanied by targeted curricular reforms that strengthen clinical reasoning, interprofess","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146180044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transforming pharmacy education and practice in Nigeria: a call for reform. 转变尼日利亚的药学教育和实践:改革的呼吁。
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2026-02-10 DOI: 10.1093/ijpp/riag011
Ifunanya Ikhile, Adaobi Uchenna Mosanya, Blessing Onyinye Ukoha-Kalu

Background: Nigeria, Africa's most populous country, faces major challenges in delivering equitable healthcare due to workforce shortages, weak regulation, and inadequate training structures. Pharmacists, as accessible healthcare professionals, are uniquely positioned to address these gaps, but pharmacy education and practice frameworks require reform.

Objective: This report provides a comprehensive overview of pharmacy education, career pathways, regulatory structures, research culture, and future directions in Nigeria, with a view to aligning the profession with global standards and national health needs.

Key findings: The pharmacy undergraduate programme of study in Nigeria is undergoing a transition from the Bachelor of Pharmacy (BPharm) to the Doctor of Pharmacy (PharmD) degree, aiming to enhance clinical competence. However, training remains largely focused on basic science rather than clinical practice, and research capacity is underdeveloped outside academia. Postgraduate opportunities exist, including Master of Science, Master of Public Health, Doctor of Philosophy, and fellowships, though structured clinical residencies are scarce. Pharmacists pursue careers in community, hospital, academic, industrial, and regulatory settings, but face limitations in scope of practice, particularly around MTM and prescribing. A national research strategy is absent, and clinician-researcher roles remain undefined. Regulatory functions are fragmented, and reimbursement models for pharmaceutical services are lacking.

Conclusions: To advance pharmacy's role in healthcare delivery, a context-sensitive, systems-level approach is essential to unlocking the profession's full potential and improving population health outcomes.Nigeria must adopt a dual-competency educational model that prepares pharmacists as both clinicians and researchers. This will require curriculum reform, interprofessional collaboration, structured postgraduate pathways, and investment in research infrastructure.

背景:尼日利亚是非洲人口最多的国家,由于劳动力短缺、监管不力和培训结构不足,该国在提供公平医疗保健方面面临重大挑战。药剂师,作为可访问的医疗保健专业人员,具有独特的定位,以解决这些差距,但药学教育和实践框架需要改革。目的:本报告全面概述了尼日利亚的药学教育、职业道路、监管结构、研究文化和未来方向,以期使该专业与全球标准和国家卫生需求保持一致。主要发现:尼日利亚的药学本科课程正在经历从药学学士(BPharm)到药学博士(PharmD)学位的过渡,旨在提高临床能力。然而,培训仍然主要集中在基础科学而不是临床实践上,而且学术界以外的研究能力不发达。研究生的机会是存在的,包括理学硕士、公共卫生硕士、哲学博士和奖学金,尽管有组织的临床住院医师很少。药剂师在社区、医院、学术、工业和监管机构中从事职业,但在实践范围方面面临限制,特别是在MTM和处方方面。缺乏国家研究战略,临床医生和研究人员的角色仍然不明确。监管职能分散,缺乏药品服务的报销模式。结论:为了提高药房在医疗保健服务中的作用,对环境敏感的系统级方法对于释放职业的全部潜力和改善人口健康结果至关重要。尼日利亚必须采用一种双重能力的教育模式,使药剂师既成为临床医生又成为研究人员。这将需要课程改革、跨专业合作、结构化的研究生路径以及对研究基础设施的投资。
{"title":"Transforming pharmacy education and practice in Nigeria: a call for reform.","authors":"Ifunanya Ikhile, Adaobi Uchenna Mosanya, Blessing Onyinye Ukoha-Kalu","doi":"10.1093/ijpp/riag011","DOIUrl":"https://doi.org/10.1093/ijpp/riag011","url":null,"abstract":"<p><strong>Background: </strong>Nigeria, Africa's most populous country, faces major challenges in delivering equitable healthcare due to workforce shortages, weak regulation, and inadequate training structures. Pharmacists, as accessible healthcare professionals, are uniquely positioned to address these gaps, but pharmacy education and practice frameworks require reform.</p><p><strong>Objective: </strong>This report provides a comprehensive overview of pharmacy education, career pathways, regulatory structures, research culture, and future directions in Nigeria, with a view to aligning the profession with global standards and national health needs.</p><p><strong>Key findings: </strong>The pharmacy undergraduate programme of study in Nigeria is undergoing a transition from the Bachelor of Pharmacy (BPharm) to the Doctor of Pharmacy (PharmD) degree, aiming to enhance clinical competence. However, training remains largely focused on basic science rather than clinical practice, and research capacity is underdeveloped outside academia. Postgraduate opportunities exist, including Master of Science, Master of Public Health, Doctor of Philosophy, and fellowships, though structured clinical residencies are scarce. Pharmacists pursue careers in community, hospital, academic, industrial, and regulatory settings, but face limitations in scope of practice, particularly around MTM and prescribing. A national research strategy is absent, and clinician-researcher roles remain undefined. Regulatory functions are fragmented, and reimbursement models for pharmaceutical services are lacking.</p><p><strong>Conclusions: </strong>To advance pharmacy's role in healthcare delivery, a context-sensitive, systems-level approach is essential to unlocking the profession's full potential and improving population health outcomes.Nigeria must adopt a dual-competency educational model that prepares pharmacists as both clinicians and researchers. This will require curriculum reform, interprofessional collaboration, structured postgraduate pathways, and investment in research infrastructure.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146149645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacy education, practice, and research in Northern Ireland: current status and future directions. 北爱尔兰的药学教育、实践和研究:现状和未来方向。
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2026-02-10 DOI: 10.1093/ijpp/riag005
Kingston Rajiah, Lezley-Anne Hanna, Lisa Smith, Roisin O'Hare, Aaron Courtenay, Deborah Lowry
{"title":"Pharmacy education, practice, and research in Northern Ireland: current status and future directions.","authors":"Kingston Rajiah, Lezley-Anne Hanna, Lisa Smith, Roisin O'Hare, Aaron Courtenay, Deborah Lowry","doi":"10.1093/ijpp/riag005","DOIUrl":"https://doi.org/10.1093/ijpp/riag005","url":null,"abstract":"","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146149662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ECHO+ model: enhancing pharmaceutical care with integrated ecological outcomes. ECHO+模式:以综合生态成果加强药学服务。
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2026-02-09 DOI: 10.1093/ijpp/riag003
Izgi Bayraktar, Mine Durusu Tanriover, Aygin Bayraktar-Ekincioglu
{"title":"ECHO+ model: enhancing pharmaceutical care with integrated ecological outcomes.","authors":"Izgi Bayraktar, Mine Durusu Tanriover, Aygin Bayraktar-Ekincioglu","doi":"10.1093/ijpp/riag003","DOIUrl":"https://doi.org/10.1093/ijpp/riag003","url":null,"abstract":"","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146142243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inclusion of non-prescription medicines in essential lists: a cross-sectional study. 将非处方药纳入基本清单:一项横断面研究。
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2026-02-09 DOI: 10.1093/ijpp/riag001
Camila Heredia, Moizza Zia Ul Haq, Navindra Persaud

Objectives: Over and behind-the-counter medicines are among the most used medicines globally, but their availability differs across countries. While they offer convenient access and fill critical gaps in healthcare, their misuse or improper administration poses risks. This study aimed to assess the inclusion patterns of over-the-counter (OTC) and behind-the-counter (BTC) medicines on essential medicines lists worldwide and examine their effect on public health in terms of accessibility and affordability, as well as the common medical conditions they are intended to address. Additionally, the study examines the regulatory frameworks governing these medicines to understand how healthcare systems balance accessibility with safety. Findings are intended to inform policy decisions aimed at optimizing medicine availability while minimizing potential harms.

Methods: This cross-sectional study involved a comparative analysis of essential medicines lists from 158 countries with publicly accessible lists. Main outcomes included the proportion of essential medicines classified as OTC or BTC, variations in their availability across countries, and a comparison with the World Health Organization's model list.

Key findings: Findings suggest significant variability in the availability of both prescription and non-prescription medicines across countries. While some nations prioritize accessibility by classifying a larger proportion of essential medicines as OTC, others implement stricter regulations to mitigate risks of misuse.

Conclusions: This study highlights the critical role of regulatory frameworks in shaping access to medicines and ensuring their safe use. Understanding global patterns in over or behind-the-counter medicine availability and their inclusion in essential medicines lists can inform policy decisions to optimize healthcare delivery.

目标:非处方药和非处方药是全球使用最多的药物之一,但它们的可得性因国家而异。虽然它们提供了方便的访问并填补了医疗保健方面的关键空白,但它们的滥用或管理不当会带来风险。本研究旨在评估非处方药(OTC)和非处方药(BTC)在全球基本药物清单上的纳入模式,并从可及性和可负担性方面检查它们对公共卫生的影响,以及它们旨在解决的常见医疗状况。此外,该研究还考察了管理这些药物的监管框架,以了解医疗保健系统如何平衡可及性与安全性。研究结果旨在为政策决策提供信息,旨在优化药物可获得性,同时最大限度地减少潜在危害。方法:这项横断面研究涉及对158个国家的基本药物清单进行比较分析,这些清单具有可公开获取的清单。主要成果包括归类为OTC或BTC的基本药物的比例、各国可获得性的差异,以及与世界卫生组织标准清单的比较。主要发现:研究结果表明,各国处方药和非处方药的可得性存在显著差异。虽然一些国家通过将更大比例的基本药物分类为OTC来优先考虑可及性,但其他国家实施更严格的法规以减轻滥用风险。结论:本研究强调了监管框架在形成药品可及性和确保其安全使用方面的关键作用。了解非处方药或非处方药可用性的全球模式,并将其纳入基本药物清单,可以为优化医疗保健服务的政策决策提供信息。
{"title":"Inclusion of non-prescription medicines in essential lists: a cross-sectional study.","authors":"Camila Heredia, Moizza Zia Ul Haq, Navindra Persaud","doi":"10.1093/ijpp/riag001","DOIUrl":"https://doi.org/10.1093/ijpp/riag001","url":null,"abstract":"<p><strong>Objectives: </strong>Over and behind-the-counter medicines are among the most used medicines globally, but their availability differs across countries. While they offer convenient access and fill critical gaps in healthcare, their misuse or improper administration poses risks. This study aimed to assess the inclusion patterns of over-the-counter (OTC) and behind-the-counter (BTC) medicines on essential medicines lists worldwide and examine their effect on public health in terms of accessibility and affordability, as well as the common medical conditions they are intended to address. Additionally, the study examines the regulatory frameworks governing these medicines to understand how healthcare systems balance accessibility with safety. Findings are intended to inform policy decisions aimed at optimizing medicine availability while minimizing potential harms.</p><p><strong>Methods: </strong>This cross-sectional study involved a comparative analysis of essential medicines lists from 158 countries with publicly accessible lists. Main outcomes included the proportion of essential medicines classified as OTC or BTC, variations in their availability across countries, and a comparison with the World Health Organization's model list.</p><p><strong>Key findings: </strong>Findings suggest significant variability in the availability of both prescription and non-prescription medicines across countries. While some nations prioritize accessibility by classifying a larger proportion of essential medicines as OTC, others implement stricter regulations to mitigate risks of misuse.</p><p><strong>Conclusions: </strong>This study highlights the critical role of regulatory frameworks in shaping access to medicines and ensuring their safe use. Understanding global patterns in over or behind-the-counter medicine availability and their inclusion in essential medicines lists can inform policy decisions to optimize healthcare delivery.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146142178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacy education and pharmacy practice in developing pharmacists as researchers: the Italian experience. 药学教育与药学实践培养药学研究者:意大利的经验。
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2026-02-09 DOI: 10.1093/ijpp/riag013
Carlo Polidori, Claudio Baiamonte, Piera Polidori

Objective: Here we describe undergraduate and graduate degrees for pharmacy-related careers, the pharmacy practice model, including community pharmacies, the research culture among pharmacists, and the future focuses for pharmacy education and practice in Italy.

Methods: All available Italian laws posted on the Education Ministry web pages have been taken into account to describe the pharmacy education organization and the career paths afforded by university degrees in pharmacy and related subjects.

Key findings: Four kind of courses are present at the School of Pharmacy in Italy: a 3-year degree for Pharmaceutical Representatives which is obligatory for those wishing to work for large or and small pharmaceutical firms to illustrate new products for doctors, community pharmacists, and hospital pharmacists. A 5-year degree in Pharmacy prepares students to work in a community pharmacy to dispense drugs requiring a prescription and to produce galenic preparations. A 5-year Chemistry and Pharmaceutical Technology degree qualifies students to be pharmacists but also provides expertise in the chemical production of drugs. Further, a 4-year graduate degree in Hospital Pharmacy provides the extra training required for pharmacy graduates to work in hospital pharmacies. Regarding research activity at community pharmacy, there are no expectations of research or research-related activity, other than the proper compilation of the obligatory registries. Instead, in the hospital setting, research is organized by hospital pharmacists, often in collaboration with medical doctors.

Conclusions: Different courses at the faculties of pharmacy are available in Italy, and research activity generally only takes place in the hospital context.

目的:在这里,我们描述了药学相关职业的本科和研究生学位,药学实践模式,包括社区药房,药剂师的研究文化,以及意大利药学教育和实践的未来重点。方法:所有可用的意大利法律张贴在教育部网页上,已考虑到描述药学教育组织和职业道路提供的大学学位药学和相关学科。主要发现:意大利药学院开设了四种课程:制药代表的3年学位是那些希望在大型或小型制药公司工作的人的必修课,为医生、社区药剂师和医院药剂师展示新产品。5年的药学学位使学生能够在社区药房工作,分发需要处方的药物并生产加仑制剂。5年的化学和制药技术学位使学生有资格成为药剂师,但也提供药物化学生产方面的专业知识。此外,四年制的医院药学研究生学位为药学毕业生在医院药房工作提供了额外的培训。关于社区药房的研究活动,除了适当编制强制性登记外,没有对研究或与研究相关的活动的期望。相反,在医院环境中,研究是由医院药剂师组织的,通常与医生合作。结论:意大利的药学院开设了不同的课程,研究活动一般只在医院进行。
{"title":"Pharmacy education and pharmacy practice in developing pharmacists as researchers: the Italian experience.","authors":"Carlo Polidori, Claudio Baiamonte, Piera Polidori","doi":"10.1093/ijpp/riag013","DOIUrl":"https://doi.org/10.1093/ijpp/riag013","url":null,"abstract":"<p><strong>Objective: </strong>Here we describe undergraduate and graduate degrees for pharmacy-related careers, the pharmacy practice model, including community pharmacies, the research culture among pharmacists, and the future focuses for pharmacy education and practice in Italy.</p><p><strong>Methods: </strong>All available Italian laws posted on the Education Ministry web pages have been taken into account to describe the pharmacy education organization and the career paths afforded by university degrees in pharmacy and related subjects.</p><p><strong>Key findings: </strong>Four kind of courses are present at the School of Pharmacy in Italy: a 3-year degree for Pharmaceutical Representatives which is obligatory for those wishing to work for large or and small pharmaceutical firms to illustrate new products for doctors, community pharmacists, and hospital pharmacists. A 5-year degree in Pharmacy prepares students to work in a community pharmacy to dispense drugs requiring a prescription and to produce galenic preparations. A 5-year Chemistry and Pharmaceutical Technology degree qualifies students to be pharmacists but also provides expertise in the chemical production of drugs. Further, a 4-year graduate degree in Hospital Pharmacy provides the extra training required for pharmacy graduates to work in hospital pharmacies. Regarding research activity at community pharmacy, there are no expectations of research or research-related activity, other than the proper compilation of the obligatory registries. Instead, in the hospital setting, research is organized by hospital pharmacists, often in collaboration with medical doctors.</p><p><strong>Conclusions: </strong>Different courses at the faculties of pharmacy are available in Italy, and research activity generally only takes place in the hospital context.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146142183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Redefining medicines optimisation: driving sustainable medicines use with the Greener Pharmacy Toolkit. 重新定义药物优化:用绿色药房工具包推动可持续药物使用。
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2026-02-02 DOI: 10.1093/ijpp/riaf137
Min Na Eii, Madeleine Winder
{"title":"Redefining medicines optimisation: driving sustainable medicines use with the Greener Pharmacy Toolkit.","authors":"Min Na Eii, Madeleine Winder","doi":"10.1093/ijpp/riaf137","DOIUrl":"https://doi.org/10.1093/ijpp/riaf137","url":null,"abstract":"","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146105339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bridging the gap in asthma care: GPs' and pharmacists' experiences to develop a model of interprofessional collaboration for asthma care in primary care in Kuwait: a qualitative interview study. 弥合哮喘护理的差距:全科医生和药剂师在科威特初级保健中发展哮喘护理跨专业合作模式的经验:一项定性访谈研究。
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2026-01-26 DOI: 10.1093/ijpp/riaf136
Amnah Taqi, Laura Lindsey, Gill Rowlands, Adam Pattison Rathbone

Objectives: In Kuwait, asthma is recognised as the most prevalent chronic condition among the population. Asthma management in primary care settings remains characterised by parallel practice, where general practitioners (GPs) and pharmacists work independently with minimal interaction. This study aimed to explore the experiences of GPs and pharmacists to develop a model of interprofessional collaboration for asthma treatment in primary care settings in Kuwait.

Methods: One-to-one semi-structured interviews were conducted with GPs and pharmacists. A convenience sample of GPs and pharmacists was recruited from primary care settings. Five primary care settings in each of the six districts in Kuwait were invited to participate. Participants were recruited either by directly approaching them in person or via email. Audio-recordings were transcribed non-verbatim and transcripts were thematically analysed using NVivo software.

Key findings: Three themes emerged from the analysis, capturing the key patterns and concepts in the participants' interviews. Theme 1: Blurred professional boundaries and hierarchical norms reflected the limited recognition of pharmacists' roles in asthma management beyond medication dispensing. Theme 2: Limited interprofessional trust described how the lack of mutual confidence hindered effective collaboration. Theme 3: Systemic barriers to working together included the absence of private counselling spaces, limited access to patient records, and unstructured communication, all impeding collaboration in asthma care.

Conclusions: Despite being co-located, GPs and pharmacists in Kuwaiti primary care experience limited collaboration. Addressing barriers at the individual, organisational, and systemic levels can support the development of a more integrated and patient-centred approach to asthma care in Kuwait and similar healthcare settings.

目的:在科威特,哮喘被认为是人口中最普遍的慢性疾病。初级保健机构的哮喘管理仍然以平行实践为特征,全科医生(gp)和药剂师独立工作,相互作用最小。本研究旨在探索全科医生和药剂师的经验,以开发科威特初级保健机构哮喘治疗的跨专业合作模式。方法:对全科医生和药师进行一对一半结构化访谈。从初级保健机构招募了全科医生和药剂师作为方便样本。科威特六个区的每一个区的五个初级保健机构被邀请参加。招募参与者的方式有两种,一种是亲自联系,另一种是通过电子邮件。对录音进行非逐字转录,并使用NVivo软件对转录进行主题分析。主要发现:分析中出现了三个主题,捕捉了参与者访谈中的关键模式和概念。主题1:模糊的专业界限和等级规范反映了对药剂师在哮喘管理中药物分配之外的角色的有限认识。主题2:有限的专业间信任描述了缺乏相互信任如何阻碍有效合作。主题3:阻碍合作的系统性障碍包括缺乏私人咨询空间、获得患者记录的机会有限以及缺乏结构化的沟通,所有这些都阻碍了哮喘护理方面的合作。结论:尽管是在同一地点,全科医生和药剂师在科威特初级保健经验有限的合作。解决个人、组织和系统层面的障碍可以支持在科威特和类似的医疗保健机构中发展更加综合和以患者为中心的哮喘护理方法。
{"title":"Bridging the gap in asthma care: GPs' and pharmacists' experiences to develop a model of interprofessional collaboration for asthma care in primary care in Kuwait: a qualitative interview study.","authors":"Amnah Taqi, Laura Lindsey, Gill Rowlands, Adam Pattison Rathbone","doi":"10.1093/ijpp/riaf136","DOIUrl":"https://doi.org/10.1093/ijpp/riaf136","url":null,"abstract":"<p><strong>Objectives: </strong>In Kuwait, asthma is recognised as the most prevalent chronic condition among the population. Asthma management in primary care settings remains characterised by parallel practice, where general practitioners (GPs) and pharmacists work independently with minimal interaction. This study aimed to explore the experiences of GPs and pharmacists to develop a model of interprofessional collaboration for asthma treatment in primary care settings in Kuwait.</p><p><strong>Methods: </strong>One-to-one semi-structured interviews were conducted with GPs and pharmacists. A convenience sample of GPs and pharmacists was recruited from primary care settings. Five primary care settings in each of the six districts in Kuwait were invited to participate. Participants were recruited either by directly approaching them in person or via email. Audio-recordings were transcribed non-verbatim and transcripts were thematically analysed using NVivo software.</p><p><strong>Key findings: </strong>Three themes emerged from the analysis, capturing the key patterns and concepts in the participants' interviews. Theme 1: Blurred professional boundaries and hierarchical norms reflected the limited recognition of pharmacists' roles in asthma management beyond medication dispensing. Theme 2: Limited interprofessional trust described how the lack of mutual confidence hindered effective collaboration. Theme 3: Systemic barriers to working together included the absence of private counselling spaces, limited access to patient records, and unstructured communication, all impeding collaboration in asthma care.</p><p><strong>Conclusions: </strong>Despite being co-located, GPs and pharmacists in Kuwaiti primary care experience limited collaboration. Addressing barriers at the individual, organisational, and systemic levels can support the development of a more integrated and patient-centred approach to asthma care in Kuwait and similar healthcare settings.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146051899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Pharmacy Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1